Search

Gdf -11 a new target to improve anemia in thalassemia.

 

β-thalassemias are characterized by ineffective red blood cell (RBC) production, leading to anemia, iron overload, and organ failure. As current treatment options for β-thalassemia are limited, there is a clear unmet need for alternative therapies.

Read more

EHA-HSH Joint Membership

Join EHA and HSH to receive up to €50 discount on your membershipThe European Hematology Association (EHA) and the Hellenic Society of Haematology (HSH), have joined forces to offer joint membership to their members.

Read more

May 8 - International Thalassaemia Day

Every year on the 8th May, Thalassaemia International Federation commemorates the International Thalassaemia Day and organises activities for raising awareness about the genetic blood disorder of thalassaemia, on general topics regarding its prevention, management and cure.

Read more

Major bleeding in patients on treatment with NOACs or VKAs in real-life: clinical presentation, management and outcome

Major bleeding in patients on treatment with NOACs or VKAs in real-life: clinical presentation, management and outcome

Limited data are available on major bleeding (MB) occurring during treatment with vitamin K (VKAs) or non-vitamin K antagonist oral anticoagulants (NOACs) outside clinical…

Read more

European Board for Accreditation in Hematology

Current committee members
Harry Schouten, The Netherlands (Chair)
Anna Porwit, Sweden (Vice-Chair)
Gunnar Birgegård, Sweden, General skills and ethics
Peter van den Burg, The Netherlands, Transfusion Medicine (ISBT)
Eleni Gavriilaki, Greece (Representative clinical hematology)
Michelle Kenyon, United Kingdom, Specialized Hematology Professional (EBMT Nurses Group)
Fionnuala Ní Áinle,…

Read more

Publications

HemaSphere - the official open access journal of EHAHemaSphere is the official open access, peer-reviewed journal of EHA, supporting hematology researchers by offering a fast and constructive review process and low publication fees.

Read more